EUVIMEDEUVIMED entdecken
Crossref

Imidazolidine‐Based Aspartate Inhibitors for Candida Infections

B Bindu, A Manikandan iD, S Jeevitha, Joe Jacob Kunju, S Vijayalakshmi

Drug Development Research · 2025

DOI: 10.1002/ddr.70074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2025. Verfasst von B Bindu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Government Arts College, Coimbatore, India. Hauptthemen laut MEDLINE: Antifungal Agents, Imidazolidines, Candida albicans, Candidiasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fungal infection gradually poses a life threat to mankind, candidiasis caused by Candida sp. is one among them. We describe the aspartate protease inhibition potentials of 12 sulfonyl‐containing imidazolidines ( 5a‐l ) anti‐candidal agents. Candida Albicans secretes aspartic proteases (Saps), one of its most important virulent agents. These hydrolytic enzymes are critical for both fungal physiological processes and host‐fungus interactions. Compounds 5a‐l were examined for their fungal aspartate protease inhibition apart from their anti‐candida activity. These findings were equipped and validated in silico using molecular docking and in vitro enzyme inhibition assays. The study found that imidazolidine derivatives inhibited aspartic protease and exhibited anti‐candida action. Conclusively, imidazolidines 5g, 5h, and 5j were perceived as the most potent anti‐candida compounds and are presently being evaluated for their preclinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsImidazolidinesCandida albicansCandidiasisAspartic Acid ProteasesMolecular Docking SimulationMicrobial Sensitivity TestsHumans

Stichwörter der Autor:innen

Candida albicansaspartate proteasecandidiasisimidazolidinemolecular dockingsecretes aspartic proteases (Saps)

Substanzen

Antifungal AgentsImidazolidinesAspartic Acid Proteases

Autor:innen und Institutionen

  • Department of Chemistry, Government Arts College, Coimbatore, India.
  • Center for Global Health Research, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha Medical College and Hospital, Chennai, India.

ORCID-Profile: A Manikandan

Zitieren

APA

Bindu, B., Manikandan, A., Jeevitha, S., Kunju, J. J., & Vijayalakshmi, S. (2025). Imidazolidine‐Based Aspartate Inhibitors for Candida Infections. Drug Development Research. https://doi.org/10.1002/ddr.70074

Vancouver

Bindu B, Manikandan A, Jeevitha S, Kunju JJ, Vijayalakshmi S. Imidazolidine‐Based Aspartate Inhibitors for Candida Infections. Drug Development Research. 2025. doi:10.1002/ddr.70074

BibTeX
@article{Bindu2025,
  author = {Bindu, B and Manikandan, A and Jeevitha, S and Kunju, Joe Jacob and Vijayalakshmi, S},
  title = {Imidazolidine‐Based Aspartate Inhibitors for Candida Infections},
  journal = {Drug Development Research},
  year = {2025},
  doi = {10.1002/ddr.70074}
}
Kostenlos starten →